Table 3.

Comparison of the intraoperative fluid management and the use of vasoactive drugs of both group

	Control group	GDFT group	P value
Net amount infused, [ml, median (IQR)]	2750 (2250–3300)	1975 (1575–2600)	< 0.001*
Crystalloid, [ml, median (IQR)]	2200 (2025–2513)	1600 (837–2100)	< 0.001*
Colloid, [ml, median (IQR)]	500 (0–1000)	500 (500–1000)	0.981
Urine output, [ml, median (IQR)]	350 (200–800)	600 (300–800)	0.041*
Blood loss, [ml, median (IQR)]	100 (0–350)	100 (50–225)	0.970
Vasopressor or inotrope, n (%)	18 (36)	27 (54)	0.072
Norepinephrine, n[mg, median (IQR)]	10 [0.04(0.02–0.10)]	13 [0.06(0.04–0.12)]
Dobutamine, n[mg,median (IQR)]	2 [2.62(0–3.50)]	6 [2.55(0–3.50)]
Phenylephrine, n[mg, median (IQR)]	6 [0.05(0.01–0.1)]	7 [0.04(0.02–0.05)]
Ephedrine, n[mg,median (IQR)]	0	1 [6]

Data are presented as median (IQR, interquartile ranges), or absolute numbers (n, % percentage)

Data were compared using Mann–Whitney U-test, or Fisher’s exact test as appropriate

^*Statistical significance (P < 0.05) compared with control